Spots Global Cancer Trial Database for A Study of CC-5013 Plus Dexamethasone Versus Dexamethasone Alone in Previously Treated Subjects With Multiple Myeloma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study of CC-5013 Plus Dexamethasone Versus Dexamethasone Alone in Previously Treated Subjects With Multiple Myeloma
Official Title: The Official Title is A Multi-center, Randomized, Parallel-group, Double-blind, Placebo Controlled Study of CC-5013 Plus Dexamethasone Versus Dexamethasone Alone in Previously Treated Subjects With Multiple Myeloma.
Study ID: NCT00424047
Conditions
Study Description
Brief Summary: To compare the efficacy of oral CC-5013 in combination with oral pulse high-dose dexamethasone to that of placebo and oral high-dose pulse dexamethasone as treatment for subjects with relapsed or refractory multiple myeloma."
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia
Peter MacCallum Cancer Centre Divsion of Haematology/Medical Oncology, East Melbourne, Victoria, Australia
The Alfred Hospital, Prahran, Victoria, Australia
Border Medical Oncology, Wodonga, Victoria, Australia
Box Hill Hospital, Box Hill, , Australia
Frankston Hospital Oncology Research, Frankston, , Australia
Royal Brisbane Hospital, Herston, , Australia
The Royal Melbourne Hospital, Parkville, , Australia
Mater Public Hospital, South Brisbane, , Australia
University Hospital of Salzburg St Johanns Spital, Salzburg, , Austria
Wilhelminenspital, Vienna, , Austria
CHU Saint-Luc, Brussel, , Belgium
UZ Gasthuisberg, Leuven, , Belgium
Centre Hospitalier Lyon Sud, Chemin Grand Revoyet, , France
Hopital Claude Huriez, Lille, , France
Centre Hospitalier Hotel-Dieu, Nantes, , France
Hopital Saint-Loius, Paris, , France
Chu de Bordeaux Groupe Hospitalier Sud, Pessac, , France
CHU Purpan, Toulouse cedex 9, , France
CHU Nancy - Hopital Brabois, Vandoeuvre, , France
Universitaetsklinikum Charite, Berlin, , Germany
Universitatsklinik ChariteMedizinische Fakultaet der HumboldtUniversitaet zu Berlin, Berlin, , Germany
Universitaetsklinikum Dusseldorf Klinik fuer Haematologie, Dusseldorf, , Germany
Universitaetsklinkum Erlangen, Erlangen, , Germany
Klininkum der Johann-Wolfgang-Goethe-Universtat, Frankfurt am Main, , Germany
Universitaetsklinikum Heidelberg Medizinische Klinik und Poliklinik V, Heidelberg, , Germany
Universitatsklinik Muenster Medizinische Klinik A, Muenster, , Germany
Klinikum der Univeristact Muenchen, Munchen, , Germany
Universitaetsklinikum Tuebingen, Tubingen, , Germany
"Alexandras" General Hospital of Athens, Athens, , Greece
University Hospital GalwayHaematology Department, Galway, Co. Galway, Ireland
Belfast City HospitalHaematology Department, Belfast, , Ireland
Hope Directorate Haematology Oncology Service St. James Hospital, Dublin 8, , Ireland
MidWestern Regional Hospital, Limerick, , Ireland
Rambam Medical Center, Haifa, , Israel
Hadassah University Hospital, Jerusalem, , Israel
Tel Aviv Sourasky Medical Center Department of Hematology, Tel Aviv, , Israel
The Chaim Sheba Medical Center, Tel Hashomer, , Israel
Policlinico Sant'Orsola-Malpighi, Bologna, , Italy
Azienda Ospedaliera San Martino, Genova, , Italy
Ospedale Niguarda Ca Granda, Milano, , Italy
Policlinico San Matteo, Pavia, , Italy
Univerita La Sapien, Roma, , Italy
Azienda Sanitaria Ospedaliera Molinette S. Giovanni Battista, Torio, , Italy
Policlinico Universitario a Gesttione diretta di Udine, Udine, , Italy
Institute of Internal Diseases University of Medicine, Gdansk, , Poland
University School of Medicine, Lublin, , Poland
Institute of Haematology and Blood Transfusion, Warsaw, , Poland
Hospital Clinic, Barcelona, , Spain
Hospital Universitario de la Princessa, Madrid, , Spain
Hospital Doce de Octubre, Madrid, , Spain
Clinica Universitaria de Navarra, Pamplona, , Spain
Hospital Universitario de Salamanca, Salamanca, , Spain
Hospital Universtario Marques de Valdecilla, Santander, , Spain
Sahlgrenska University Hospital Department of Hematology and Coagulation, Goteborg, , Sweden
Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, , Switzerland
Kantonsspital St. Gallen, St. Gallen, , Switzerland
Universitätsspital Zürich, Zürich, , Switzerland
Cherkassy Regional Oncology Center, Cherkassy, , Ukraine
Dnepropetrovsk City Clinical Hospital #4, Dnepropetrovsk, , Ukraine
Kiev Bone Marrow Transplantation Center Bone Marrow Department, Kiev, , Ukraine
Institute of Hematology and Transfusiology of the UAMS Department of blood diseases, Kiev, , Ukraine
Institute of Blood Pathology and Transfusion Medicine of the UAMS, Lviv, , Ukraine
Institute of Blood Pathology and Transfusion Medicine of the UAMS Hematology Department, Lvov, , Ukraine
Odess Regional Clinical Hospital, Odessa, , Ukraine
Zhitomir Regional Clinical Hospital, Zhitomir, , Ukraine
University College Hospital Trust, London, Bloomsbury, United Kingdom
Bristol Haematology and Oncology Centre, Bristol, , United Kingdom
Haematology Dept, 4th Floor Thomas Guy House, London, , United Kingdom
Contact Details
Name: Robert Knight, MD
Affiliation: Celgene Corporation
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
